MedTrace Logo

Retrospective Evaluation of the Long-term Effectiveness of the CR500™ SINGLE-DOSE GEL Medical Device in Patients With Knee Osteoarthritis (KOA)

NCT07322770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2026-01-07

No results posted yet for this study

Summary

Evaluate the long-term efficacy of the CR500™ therapy in patients with knee OA.

Conditions

Interventions

DEVICE

CR 500™ SINGLE-DOSE GEL

CR 500™ SINGLE-DOSE GEL is a hydrogel to be applied to intact skin, useful to attenuate the physiological degeneration of cartilage typical of osteoarthritic processes. The presence of sodium hyaluronate facilitates the movement of joints and tendons for greater mobility and flexibility

Sponsors & Collaborators

  • Contrad Swiss SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-17
Primary Completion
2025-08-13
Completion
2025-08-13

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07322770 on ClinicalTrials.gov